Eli Lilly's JAK inhibitor demonstrated 80% scalp hair regrowth in 42.4% of adolescents with severe alopecia areata after just 36 weeks of treatment, outperforming placebo in the Phase 3 BRAVE-AA-PEDS trial.
Researchers will present findings at the American Academy of Neurology’s 77th Annual Meeting on how OTC pain relievers may be linked to faster concussion recovery.
Folic acid taken during the first trimester led to improved verbal skills and behavior in children at age 6, with no evidence of negative effects, according to new research to be presented at the American Academy of Neurology's 77th Annual Meeting.
"These differences were largely driven by the high rate of adverse events leading to study discontinuation in the OIT-treated participants, despite receiving omalizumab treatment at the initiation of therapy."
A novel dumbbell-shaped thrombectomy device, called the Venus-TD, demonstrated high recanalization rates and favorable outcomes among patients with cerebral venous sinus thrombosis.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Compared to those with longer telomeres, individuals with the shortest telomeres demonstrated an 8% higher risk of stroke, a 19% higher risk of dementia, and a 14% higher risk of late-life depression.
A study demonstrates that administering intra-arterial tenecteplase after mechanical clot removal significantly improves 90-day outcomes for stroke patients, with 44% higher likelihood of excellent recovery compared to standard care alone.
Investigators detailed the potential risk of cardiomyopathy in young adult patients with attention-deficit/hyperactivity disorder (ADHD) who were treated with stimulants.